Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva’s Generic Zoloft Launch, And New Jerusalem Plant, Remain Idle

Executive Summary

Teva's supply chain challenges appear to have caught up with the company in the form of further delays of its launch of Zoloft generics

You may also be interested in...



Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver

The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association

Generic Drug Service, Not Pricing, Is Key Performance Factor – Lehman’s Silver

The success of generic companies will be determined more by the breadth and quality of their offerings than product pricing, Lehman Brothers Senior VP-Specialty Pharmaceutical Research Rich Silver told the Generic Pharmaceutical Association

Teva’s new plant no longer idle

Teva's new Jerusalem plant passed FDA inspection last month and is now operating, the generic firm announces during an analyst call Feb. 13. The plant was scheduled to be fully operational in early 2006 (1"The Pink Sheet" Aug. 14, 2006, p. 6). CEO Israel Makov says the plant started with a capacity of four billion tablets a year, with a goal to double that by year end...

Related Content

UsernamePublicRestriction

Register

PS047479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel